Dr. Antonino Puglisi has just been awarded a two year long Marie Sklodowska Curie Action Individual Fellowship (MSCA-IF) in our group.
The project, which scored 96.40% in Evaluation Summary Report, will focus on a novel class of smart polymer nanoparticles (NanoMops) based on cyclodextrin-containing polymers to be used to contrast the effect of the rare genetic disorder Niemann-Pick Disease Type C (NPC).
NPC, also known as “childhood Alzheimer’s” is a devastating genetic disorder caused by the accumulation of cholesterol particularly in the brain with an incidence in the EU of 1 per 100,000 people.
The interdisciplinary project will create new important international and inter-sectoral partnerships with excellent academic and industrial players while reaching out to charity organisations, raising awareness and networking researchers and key stakeholders in the area of NPC
More information can be found here http://antoninopuglisi7.wixsite.com/cyclochem/about-me